Abstract
5027^ Background: Abi (CYP17A1 and lyase inhibitor) and cabo (multi-tyrosine kinase inhibitor including MET and VEGFRs) have complementary mechanisms of action. Both have single agent activity in C...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
